These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Alterations in left ventricular function and coronary hemodynamics with captopril, hydralazine and prazosin in chronic ischemic heart failure: a comparative study. Rouleau JL; Chatterjee K; Benge W; Parmley WW; Hiramatsu B Circulation; 1982 Apr; 65(4):671-8. PubMed ID: 7037220 [No Abstract] [Full Text] [Related]
25. [Use of vasodilator agents in circulatory insufficienty]. Halawa B Wiad Lek; 1979 Nov; 32(22):1617-20. PubMed ID: 120075 [No Abstract] [Full Text] [Related]
26. [Modern vasodilator medication in refractory cardiac insufficiency]. Stanciu L; Branea I; Riviş I; Radivoievici A; Mancaş S; Păunescu A Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1983; 35(2):129-34. PubMed ID: 6139858 [No Abstract] [Full Text] [Related]
27. Pharmacodynamic basis of the use of vasodilators in the treatment of heart failure. Taylor SH Med J Aust; 1980 Jul; 2(SP1):19-35. PubMed ID: 6775178 [No Abstract] [Full Text] [Related]
28. Influence of oral prazosin therapy on exercise hemodynamics in patients with severe chronic heart failure. Chatterjee K; Rubin SA; Ports TA; Parmley WW Am J Med; 1981 Jul; 71(1):140-6. PubMed ID: 7246571 [TBL] [Abstract][Full Text] [Related]
29. Prazosin and congestive heart failure: short- and long-term therapy. Rouleau JL; Warnica JW; Burgess JH Am J Med; 1981 Jul; 71(1):147-52. PubMed ID: 7246572 [TBL] [Abstract][Full Text] [Related]
30. [Prazosin in the treatment of chronic resistant heart failure]. Kleinman Y; Tzivoni D Harefuah; 1981 Apr; 100(8):398-401. PubMed ID: 7274816 [No Abstract] [Full Text] [Related]
32. [Long-term treatment of cardiac insufficiency with prazosin]. Grolleau R; Errera J; Gallay P Ann Cardiol Angeiol (Paris); 1984; 33(4):247-51. PubMed ID: 6465817 [No Abstract] [Full Text] [Related]
33. Effectiveness of long-term vasodilator administration in the treatment of chronic left ventricular failure. Franciosa JA Prog Cardiovasc Dis; 1982; 24(4):319-30. PubMed ID: 7034048 [No Abstract] [Full Text] [Related]
34. Sustained effectiveness of chronic prazosin therapy in severe chronic congestive heart failure. Bertel O; Burkart F; Bühler FR Am Heart J; 1981 May; 101(5):529-33. PubMed ID: 7223592 [TBL] [Abstract][Full Text] [Related]
35. Current indications for vasodilator therapy for left ventricular failure. Franciosa JA Compr Ther; 1985 Mar; 11(3):39-46. PubMed ID: 2983926 [No Abstract] [Full Text] [Related]
36. Effects of red rest and prazosin in congestive heart failure. Thaulow E; Ihlen H; Kjekshus J; Forfang K; Storstein O Acta Med Scand; 1982; 212(3):131-6. PubMed ID: 7148503 [TBL] [Abstract][Full Text] [Related]
37. [Hemodynamic effects of prazosin in chronic congestive heart failure]. Bassand JP; Becque O; Berthout P; Vial Y; Magnin D; Bernard Y; Maurat JP Arch Mal Coeur Vaiss; 1980 Jun; 73(6):747-56. PubMed ID: 6779769 [No Abstract] [Full Text] [Related]
38. Guidelines for vasodilator therapy of congestive heart failure in infants and children. Artman M; Graham TP Am Heart J; 1987 Apr; 113(4):994-1005. PubMed ID: 3031972 [No Abstract] [Full Text] [Related]